🇺🇸 FDA
Patent

US 10590082

N-(5-((aryl or heteroaryl)methyloxy)pentyl)-substituted iminosugars as inhibitors of glucosylceramide synthase

granted A61PA61P3/00

Quick answer

US patent 10590082 (N-(5-((aryl or heteroaryl)methyloxy)pentyl)-substituted iminosugars as inhibitors of glucosylceramide synthase) held by ACADEMISCH MEDISCH CENTRUM expires Mon Mar 12 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
ACADEMISCH MEDISCH CENTRUM
Grant date
Tue Mar 17 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 12 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
25
CPC classes
A61P, A61P3/00